Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2003
04/10/2003US20030069258 Novel guanidine mimics factor Xa inhibitors
04/10/2003US20030069257 Benzimidazole and pyridylimidazole derivatives
04/10/2003US20030069250 Anticoagulants
04/10/2003US20030069249 Analgesics; central nervous system disorders
04/10/2003US20030069248 Antiinflammatory agents; controlling cell cycle
04/10/2003US20030069245 Aids therapy
04/10/2003US20030069243 Novel substituted imidazole compounds
04/10/2003US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
04/10/2003US20030069239 Anticancer agents
04/10/2003US20030069234 CXCR3 antagonists
04/10/2003US20030069230 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
04/10/2003US20030069223 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030069140 Herbicides
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462419A1 N-heterocyclyl hydrazides as neurotrophic agents
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2461976A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
04/10/2003CA2460594A1 Mch receptor antagonists
04/09/2003EP1300398A1 Propane-1,3-dione derivatives
04/09/2003EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
04/09/2003EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
04/09/2003EP1299381A1 Substituted quinazoline derivatives and their use as inhibitors
04/09/2003EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase
04/09/2003EP1299361A1 Pyrazole derivatives
04/09/2003EP1299356A1 Novel compounds
04/09/2003EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
04/09/2003EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
04/09/2003EP1198453B1 N-(indolcarbonyl-)piperazin derivatives
04/09/2003EP1183262A4 Intermediates for and synthesis of 3-methylene cephams
04/09/2003EP0758327B1 Pyranone compounds useful to treat retroviral infections
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003EP0674623B1 Bicyclic fibrinogen antagonists
04/09/2003CN1409709A Substituted bisindolylmaleimides for inhibition of cell proliferation
04/09/2003CN1409704A Heterocycle derivatives and drugs
04/09/2003CN1105113C Fungicidal pyrimidinones
04/09/2003CN1104898C Ocular tension depressant
04/08/2003US6545162 Solid phase biosynthesis of viricide antibiotic
04/08/2003US6545071 Stabilizer mixtures
04/08/2003US6545038 Heterocyclic metalloprotease inhibitors
04/08/2003US6545015 Useful in therapy of bacterial infections, fungal infections
04/08/2003US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/08/2003US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
04/08/2003US6544985 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits
04/08/2003US6544981 Anticoagulants, cardiovascular disorders
04/08/2003US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care
04/08/2003CA2224983C Triazole antifungal agents
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2097824C Functionalized vinyl azoles and their use
04/08/2003CA2062271C Derivatives of substituted imidazol-2-one and process for their preparation
04/08/2003CA2001903C 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
04/03/2003WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027097A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
04/03/2003WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
04/03/2003WO2003027078A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
04/03/2003WO2003027076A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
04/03/2003WO2003027074A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
04/03/2003WO2003027068A2 Substituted amines for the treatment of neurological disorders
04/03/2003WO2003026666A1 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors
04/03/2003WO2003026665A1 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
04/03/2003WO2003026664A1 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
04/03/2003WO2003026663A1 Process for making substituted pyrazoles
04/03/2003WO2003026650A1 3-(heteroarylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003026649A1 Methods of increasing endogenous testosterone levels
04/03/2003WO2003026648A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
04/03/2003WO2003026647A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
04/03/2003WO2003026587A2 Compounds useful for treating hepatitus c virus
04/03/2003WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7
04/03/2003US20030065179 Diabetic therapy
04/03/2003US20030065176 Anticoagulant; cardiovascular disorders
04/03/2003US20030065007 Analgesics; psychological disorders; antidepressants
04/03/2003US20030064997 Novel compounds
04/03/2003US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/03/2003US20030064986 Method for preparing pyrimidone derivatives with antifungal activity
04/03/2003US20030064982 Pyrazole compounds useful as protein kinase inhibitors
04/03/2003US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease
04/03/2003US20030064980 Respiratory system disorders; antiinflammatory agents
04/03/2003US20030064977 Viricides
04/03/2003US20030064332 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
04/03/2003CA2461603A1 Substituted amines for the treatment of neurological disorders
04/03/2003CA2461467A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
04/03/2003CA2461128A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
04/03/2003CA2461095A1 Process for making substituted pyrazoles
04/03/2003CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
04/03/2003CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003CA2458661A1 Methods of increasing endogenous testosterone levels
04/02/2003WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds
04/02/2003EP1298496A2 Electrophotographic organophotoreceptors
04/02/2003EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer
04/02/2003EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers
04/02/2003EP1297175A2 Methods and compounds for modulating nuclear receptor coactivator binding
04/02/2003EP1296977A1 Heteroaryl-phenyl substituted factor xa inhibitors
04/02/2003EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
04/02/2003EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
04/02/2003EP1296974A2 2-cyanopyrrolidine derivatives and their use as medicaments
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 626